Date | Time | Source | Headline | Symbol | Company |
06/10/2016 | 5:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
06/10/2016 | 5:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
06/10/2016 | 5:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
06/10/2016 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
05/05/2016 | 7:35AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
05/04/2016 | 8:35AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ESPR | Esperion Therapeutics Inc |
05/04/2016 | 8:31AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ESPR | Esperion Therapeutics Inc |
05/04/2016 | 8:05AM | GlobeNewswire Inc. | Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2016 Financial Results | NASDAQ:ESPR | Esperion Therapeutics Inc |
04/28/2016 | 8:15AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/11/2016 | 10:03PM | GlobeNewswire Inc. | ESPERION 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC ... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/11/2016 | 9:35PM | Business Wire | INVESTOR DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Esperion Therapeutics, Inc. | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/11/2016 | 9:30AM | Business Wire | March 14 Deadline Alert: Law Offices of Howard G. Smith Reminds Esperion Therapeutics, Inc. Investors of Upcoming Lead Plaint... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 8:46PM | GlobeNewswire Inc. | Scott + Scott, LLP Notifies Investors That Monday, March 14, 2016 is Last Day to File Lead Plaintiff Papers in Esperion Thera... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | Esperion Therapeutics to Present at the Barclays Global Healthcare Conference | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | Hagens Berman Reminds Esperion Therapeutics, Inc. (NASDAQGM: ESPR) Investors of March 14, 2016 Lead Plaintiff Deadline | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | SECURITIES NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important March 14, 2016 Deadline in Class... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | INVESTOR ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Lawsuit Involving Esperion Therapeutics, Inc... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Le... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/09/2016 | 7:46PM | GlobeNewswire Inc. | Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/08/2016 | 2:46PM | Business Wire | Scott + Scott, LLP Notifies Investors that Monday, March 14, 2016 Is Last Day to File Lead Plaintiff Papers in Esperion Thera... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/08/2016 | 10:30AM | Business Wire | Glancy Prongay & Murray LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Esperion The... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/08/2016 | 9:52AM | PR Newswire (US) | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/07/2016 | 11:39AM | Business Wire | Scott + Scott, LLP Notifies Investors of Monday, March 14, 2016 Deadline in Esperion Therapeutics (ESPR) Securities Case | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/04/2016 | 9:15PM | Business Wire | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Esperion Therapeutics, Inc. | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/03/2016 | 10:17AM | Business Wire | Scott + Scott, LLP Notifies Investors of Monday, March 14, 2016 Deadline in Esperion Therapeutics (ESPR) Securities Case | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/02/2016 | 2:15PM | Business Wire | Scott + Scott, LLP Reminds Investors of Monday, March 14, 2016 Deadline to File Lead Plaintiff Papers in Esperion Therapeutic... | NASDAQ:ESPR | Esperion Therapeutics Inc |
03/02/2016 | 7:24AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ESPR | Esperion Therapeutics Inc |
02/26/2016 | 10:03PM | PR Newswire (US) | The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class ... | NASDAQ:ESPR | Esperion Therapeutics Inc |
02/26/2016 | 2:00PM | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit & a Lead P... | NASDAQ:ESPR | Esperion Therapeutics Inc |
02/23/2016 | 3:00PM | Business Wire | ESPERION INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Esperion Therapeutics, Inc. | NASDAQ:ESPR | Esperion Therapeutics Inc |